Skip to main content
The MattCorc Podcast

The MattCorc Podcast

By Life Sciences Rush Hour - Inve

A daily, 5-10 minute, podcast where we talk about risk and investing. Find out more at mattcorc.com or shoot me an email at matt@mattcorc.com. I would love to hear any feedback, including topic suggestions and insurance questions. If you would like to join me on an episode, send me an email.
Available on
Apple Podcasts Logo
Castbox Logo
Google Podcasts Logo
Overcast Logo
Pocket Casts Logo
RadioPublic Logo
Spotify Logo
Currently playing episode

May 17, 2018

The MattCorc PodcastMay 17, 2018

00:00
08:30
Where does the market go from here? Will retail investors sell?

Where does the market go from here? Will retail investors sell?

We talk about the recent market turmoil and how that will impact investor actions. Will investors stick to their guns or succumb and sell if the market continues to sell off. A few comments on Medtronic’s settlement and how insurance could have been implemented to reduce the financial burden for Medtronic.
Nov 21, 201809:22
What’s the deal with GE?

What’s the deal with GE?

GE has seen its market cap decrease by over $200B since 2016 and it now trades at around $8. Is this the correct value or should it be higher or perhaps lower?
Nov 16, 201808:34
We changed our name and Amazon announced their new locations!

We changed our name and Amazon announced their new locations!

Why we changed our name to the MattCorc Podcast. Who is taking the most risk with the Amazon headquarters, Amazon or the local/state government? What is Waymo? The first autonomous ride hailing service is getting ready to launch in Arizona.
Nov 14, 201810:31
A $500 Million Biotech IPO. Amarin Data

A $500 Million Biotech IPO. Amarin Data

Moderna plans the biggest biotech IPO ever and we learn more about Amarin’s clinical study. Was mineral oil the best choice of placebo? Lessons we can learn from Amarin about D&O insurance.
Nov 12, 201809:04
Herd Mentality. Why D&O benchmarking is a sales ploy. What to use to make a more informed decision.

Herd Mentality. Why D&O benchmarking is a sales ploy. What to use to make a more informed decision.

I talk about how brokers use benchmarking to sell you more D&O insurance. Brokers take advantage of herd mentality so insurers buy more D&O than they need.
Nov 09, 201809:14
Why cost should only be one consideration

Why cost should only be one consideration

Cost and its importance are discussed. Minor differences in coverage can cause major headaches when you have a claim.
Nov 06, 201805:25
S&P Companies not as negative; Gene Therapy manufacturing is stretched thin

S&P Companies not as negative; Gene Therapy manufacturing is stretched thin

Happy national doughnut day! Fewer companies in the S&P are providing negative guidance. What does this mean? How CFOs are protecting their balance sheets in the event their manufacturing is disrupted.
Nov 05, 201807:21
Lessons from Halloween when your kids have peanut allergies

Lessons from Halloween when your kids have peanut allergies

Why is Aimmune (AIMT) up today? Is it because Halloween reminded investors how many types of candy have peanuts in them? A lesson on how to make sure you aren’t missing significant coverage gaps in your insurance program. Hint: I learned it from checking my kids Halloween candy.
Nov 01, 201808:57
Swimming and the Dow Jones

Swimming and the Dow Jones

How my first time swimming in a lap pool in years was a good metaphor for today’s market and some other interesting facts on the financial markets.
Oct 29, 201805:10
President’s Drug Pricing Speech and New CA Sexual Harassment Law

President’s Drug Pricing Speech and New CA Sexual Harassment Law

An overview of the President’s drug pricing proposal and what the new California sexual harassment law could mean for your insurance.
Oct 25, 201808:50
M&A Activity - Will Market Forces Play a Role?

M&A Activity - Will Market Forces Play a Role?

With biotech stocks sinking, the XBI just hit a 52 week low, and interest rates rising will we see an urgency for acquisitions to be done?
Oct 24, 201803:29
Episode 36 - Concept or Concrete?

Episode 36 - Concept or Concrete?

Quick post on why Insurance buying doesn’t need to be so abstract.
Oct 19, 201802:09
Episode 35 - McDermott Will & Emery Dealmaking Symposium Recap

Episode 35 - McDermott Will & Emery Dealmaking Symposium Recap

A ton was learned at the MWE life science deal making symposium and here I share that with you.
Oct 18, 201809:57
Episode 34 - DeviceTalks Recap

Episode 34 - DeviceTalks Recap

A synopsis of DeviceTalks Boston. Pathways to acquisition, hurdles that you might face and how to derisk your company to make it more appealing to investors and acquiring companies.
Oct 17, 201807:39
Episode 33 - Chinese Espionage and Cyber Coverage

Episode 33 - Chinese Espionage and Cyber Coverage

What can we learn from the alleged Chinese cyber espionage incident and how cyber insurance could respond.
Oct 04, 201806:18
Episode 32 - Can the Biotech IPO Market Sustain Itself?
Oct 03, 201805:36
I’m Doing an IPO and My D&O Insurance is Expensive

I’m Doing an IPO and My D&O Insurance is Expensive

Why D&O Insurance is expensive for life science companies and how the stage your company is in impacts pricing.
Oct 01, 201808:03
FDA Condemns Undamaged Product - Insurance Should Have Paid

FDA Condemns Undamaged Product - Insurance Should Have Paid

A client had a fire and $250,000 in product was destroyed. Undamaged condemned stock was valued at over $500,000 but there insurance did not cover it. Find out why that should never happen.
Sep 25, 201805:16
Episode 29 - MD Bio-Tech Conference Recap

Episode 29 - MD Bio-Tech Conference Recap

A recap of the Maryland Bio-Tech Conference that I recently attended.
Sep 21, 201811:29
Episode 28 - NJTC CFO Forum Recap

Episode 28 - NJTC CFO Forum Recap

A recap of the CFO Forum put on by the NJ Tech Council. The speaker was Jim Mastakas who was the CFO of Amneal when they merged with Impax Labs
Sep 19, 201810:20
Episode 27 - Monday Market Update

Episode 27 - Monday Market Update

The impacts of Hurricane Florence on the property insurance market are discussed
Sep 17, 201807:51
Common Question Friday #1

Common Question Friday #1

Why does a pre-clinical company need insurance?
Sep 14, 201806:38
Apple Watch, Transitioning From Digital Health to Med Device

Apple Watch, Transitioning From Digital Health to Med Device

A quick synopsis of how insurance liability changes as a company enters the realm to an FDA regulated product.
Sep 13, 201805:37
Hurricane Florence and Where to Look for Property Coverage

Hurricane Florence and Where to Look for Property Coverage

Where to look for additional coverage in your proprty policy above and beyond replacing your building or contents. Things to be aware of that could reduce coverage.
Sep 12, 201809:19
Abbvie Testosterone Settlement and Product Liability

Abbvie Testosterone Settlement and Product Liability

I discuss the Abbvie testosterone settlement and the role of product liability insurance could play. Hurricanes and property insurance.
Sep 11, 201810:26
Episode 22 - Boston Biotech Week and RESI

Episode 22 - Boston Biotech Week and RESI

A recap of Boston Biotech Week and the RESI conference. How insurance can help you stand out with investors.
Sep 10, 201808:48
Episode 21 - Patent Insurance...It’s a Real Thing

Episode 21 - Patent Insurance...It’s a Real Thing

An overview of patent insurance and what it can do.
Aug 30, 201809:29
Episode 20 - Opioid Settlement and Product Liability

Episode 20 - Opioid Settlement and Product Liability

A discussion on Product Liability insurance in relation to a possible opioid settlement. Wage & Hour lawsuits are on the rise but there is a solution.
Aug 29, 201810:28
What happens when your supply chain is disrupted?

What happens when your supply chain is disrupted?

In the wake of an API manufacturer being shut down in China I discuss using insurance to mitigate the cash flow disruption.
Aug 24, 201807:17
Should Public Companies Only Report Earnings Semi-Annually?

Should Public Companies Only Report Earnings Semi-Annually?

The possible impacts on moving from quarterly to semiannual reporting periods for public companies on the D&O insurance marketplace
Aug 23, 201807:55
Episode 17 - Getting Your Product Approved

Episode 17 - Getting Your Product Approved

Amicus and Alnylam both got FDA approval last week. Find out how that can change their risk profile.
Aug 14, 201810:28
Cyber Insurance - Is Change Coming?

Cyber Insurance - Is Change Coming?

I discuss the PGA Championship being cyber extorted, CA Consumer Privacy Act and the role insurance plays in both of these events.
Aug 09, 201807:49
Apple, AIG, D&O Insurance and Patents

Apple, AIG, D&O Insurance and Patents

We discuss Apple hitting the $1 trillion mark, AIG going the other way, government taking your patent and D&O insurance
Aug 02, 201810:53
Episode 14 - Securities Class Action Filings and D&O Cover

Episode 14 - Securities Class Action Filings and D&O Cover

I talk about the prevalence of securities class action filings and how D&O can protect you. I also discuss how we should not choose limits solely by what our peers have in place.
Jul 31, 201808:10
Episode 13 - Sarepta and Insuring Regulatory Risk

Episode 13 - Sarepta and Insuring Regulatory Risk

I talk about what we can learn from Sarepta's clinical hold and how they could insure such an event for their commercial product.
Jul 26, 201804:19
Episode 12

Episode 12

Jul 25, 201806:04
Keryx Merger and Supply Chain issues

Keryx Merger and Supply Chain issues

Today we are reminded, due to the news that Keryx and Akebia are merging, of what happens when you have a supply chain issue.
Jun 28, 201806:08
Insuring the Black Swan

Insuring the Black Swan

Aquinox disaster and what you can do to protect your company from Black Swans.
Jun 27, 201809:27
Stryker Acquisition, CRISPR problems

Stryker Acquisition, CRISPR problems

Recap of today’s big events. Stryker bidding on Boston Scientific. CRISPR might cause cancer.
Jun 11, 201804:42
Liability for Digital Health Products

Liability for Digital Health Products

I discuss liability when a digital health product works but something bad happens. Blurring the lines of medtech and digital health.
Jun 05, 201807:57
Medtech Conference 2018

Medtech Conference 2018

A brief review of the 2018 Medtech conference in Minneapolis
Jun 04, 201813:51
Episode 6 - IPO and D&O

Episode 6 - IPO and D&O

IPO market is healthy. Rockwell Medical and how D&O insurance could provide balance sheet protection
May 25, 201809:05
Episode 5 - Keytruda, Rockwell Medical, Spoilage

Episode 5 - Keytruda, Rockwell Medical, Spoilage

Keytruda does it again in the clinic and also changes to M&A landscape. What’s going on at Rockwell Medical? Is your product temperature sensitive?
May 23, 201806:30
Episode 4 - FDA and Hemophilia

Episode 4 - FDA and Hemophilia

Quick rundown on FDA related news, Hemophilia news and how right to try could impact the insurance market
May 22, 201803:54
May 17, 2018

May 17, 2018

May 17, 201808:30
May 15, 2018

May 15, 2018

May 15, 201805:01
May 11, 2018

May 11, 2018

Episode 1 - Drug Pricing and Ford
May 14, 201807:29